BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Tuesday, Mar 10, 2026 7:33 am ET1min read
BCTX--

BriaCell Therapeutics Corp. will present four posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, highlighting research on its cellular immunotherapy platform, including a pivotal Phase 3 study of Bria-IMT and research on Bria-OTS+, a next-generation personalized off-the-shelf immunotherapy program. Poster titles and presentation details will be available on March 17, 2026. The company is a clinical-stage biotechnology firm developing novel immunotherapies to transform cancer care.

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet